Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check3 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3, indicating a minor update to the study record.SummaryDifference0.1%

- Check11 days agoChange DetectedPage revision label updated from v3.6.0 to v3.6.2, indicating a new revision of the page content. This appears to be a minor maintenance update and does not modify study data or user-facing information.SummaryDifference0.1%

- Check18 days agoChange DetectedPublications section added to the study record with a PubMed citation related to the HSV-2 vaccine research. It also notes that publications are auto-filled from PubMed and may not all pertain directly to the study.SummaryDifference0.3%

- Check25 days agoChange DetectedNew recruitment status indicates enrollment is closed; new user guidance sections were added, the Intervention/Treatment header formatting was adjusted, and the revision label updated to v3.6.0.SummaryDifference0.5%

- Check32 days agoChange DetectedThe page revision label has been updated to `v3.5.5`, replacing the previous `v3.5.4`. This reflects a minor page build/update.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision label v3.5.4 was added and the previous v3.5.3 was removed. This reflects an internal platform update and does not alter any study data or visible content.SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.